Browsing Tag
EQT Life Sciences
2 posts
Neurent Medical secures €25m growth debt to expand NEUROMARK commercialization
Neurent Medical has secured a €25 million growth-debt facility from Claret Capital after completing a €62.5 million Series C, giving the chronic rhinitis device company additional commercial firepower without immediately returning to shareholders for another equity round.
Swiss biotech company Noema Pharma secures CHF130m to advance CNS therapies
Basel, Switzerland-based Noema Pharma, a clinical-stage biotech company, has announced the successful close of its Series B financing…